Top Biotechnology & Medical Research stocks in Australia

Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.

Name
Market Cap
Price to Earnings
TTM
Dividend Yield
% TTM
au flag iconTLXTelix PharmaceuticalsAU$9.74bn166.87n/a
au flag iconMSBMesoblastAU$3.45bnn/an/a
au flag iconCU6Clarity PharmaceuticalsAU$1.22bnn/an/a
au flag iconOPTOptheaAU$1.20bnn/an/a
au flag iconPYCPYC TherapeuticsAU$566.62mn/an/a
au flag iconIMMImmutepAU$476.48mn/an/a
au flag iconIMUImugeneAU$263.53mn/an/a
au flag iconDXBDimerixAU$258.59mn/an/a
au flag iconRACRace OncologyAU$205.22mn/an/a
au flag iconALAArovella TherapeuticsAU$204.86mn/an/a
au flag iconCGSCogstateAU$201.52m23.44n/a
au flag iconPARParadigm BiopharmaceuticalsAU$190.95mn/an/a
au flag iconLTPLtr PharmaAU$100.38mn/an/a
au flag iconAGNArgenica TherapeuticsAU$87.83mn/an/a
au flag iconACWActinogen MedicalAU$84.33mn/an/a
au flag iconPIQProteomics International LaboratoriesAU$83.12mn/an/a
au flag iconBXNBioxyneAU$79.82mn/an/a
au flag iconATHAlterity TherapeuticsAU$62.94mn/an/a
au flag iconGD8GO-DX (Aust)AU$61.94mn/an/a
au flag iconNTINeurotech InternationalAU$44.77mn/an/a